BELITE BIO (BLTE) stock: insider trades, news & valuation
Heavy selling
Close · Oct 9, 2026
$154.49
+1.3% on the day
+96.8% over 12 months
52-week range $78.50 – $193.61
Share price and insider trades
BLTE closeInsider buyInsider sale
Bought, 12 months$0
Sold, 12 months$40.6M
Insiders buying0
Insiders selling5
BELITE BIO insider trading at a glance (Oct 9, 2026): in the past 12 months, 0 insiders bought $0 and 5 sold $40.6M of BLTE stock on the open market.
Get emailed when insiders cluster-buy stocks like BLTE
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
BLTE insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | $83K | 8 |
| Q3 2026 | — | 0 | $32.0M | 42 |
| Q2 2026 | — | 0 | $8.5M | 125 |
Valuation, profit and volume
P/E (trailing)n/aSector median —
Market value—
Profit margin—Revenue growth —
Volume vs. 50-day0.8×Last 5 sessions
Insiders' paper profit—On all tracked purchases —
Summary
Over the past 12 months, 0 BELITE BIO, INC insiders reported open-market purchases totaling $0, while 5 insiders reported sales totaling $40.6M. 162 of 175 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Oct 5SEC | Hendrik Peter SchollChief Medical Officer | Sell Plan | 20014,800 held (−1%) | $163.62 | $33K | -5.6% | — |
| Oct 5SEC | Hendrik Peter SchollChief Medical Officer | Sell Plan | 12014,656 held (−1%) | $165.49 | $20K | -6.6% | — |
| Oct 5SEC | Hendrik Peter SchollChief Medical Officer | Sell Plan | 7814,528 held (−1%) | $167.59 | $13K | -7.8% | — |
| Oct 5SEC | Hendrik Peter SchollChief Medical Officer | Sell Plan | 5014,606 held (−0%) | $166.44 | $8K | -7.2% | — |
| Oct 5SEC | Hendrik Peter SchollChief Medical Officer | Sell Plan | 2414,776 held (−0%) | $164.64 | $4K | -6.2% | — |
| Oct 5SEC | Hendrik Peter SchollChief Medical Officer | Sell Plan | 1414,502 held (−0%) | $169.36 | $2K | -8.8% | — |
| Oct 5SEC | Hendrik Peter SchollChief Medical Officer | Sell Plan | 1214,516 held (−0%) | $168.21 | $2K | -8.2% | — |
| Oct 5SEC | Hendrik Peter SchollChief Medical Officer | Sell Plan | 214,500 held (−0%) | $170.02 | $340 | -9.1% | — |
| Sep 9SEC | Yu-hsin LinCEO | Sell Plan | 11,080108,454 held (−9%) | $191.15 | $2.1M | -19.2% | — |
| Sep 9SEC | Yu-hsin LinCEO | Sell Plan | 8,75272,834 held (−11%) | $197.36 | $1.7M | -21.7% | — |
| Sep 9SEC | Yu-hsin LinCEO | Sell Plan | 8,955120,134 held (−7%) | $189.34 | $1.7M | -18.4% | — |
| Sep 9SEC | Yu-hsin LinCEO | Sell Plan | 8,11196,134 held (−8%) | $193.13 | $1.6M | -20.0% | — |
| Sep 9SEC | Yu-hsin LinCEO | Sell Plan | 7,800138,334 held (−5%) | $186.32 | $1.5M | -17.1% | — |
| Sep 9SEC | Yu-hsin LinCEO | Sell Plan | 6,09087,644 held (−6%) | $195.62 | $1.2M | -21.0% | — |
| Sep 9SEC | Yu-hsin LinCEO | Sell Plan | 6,05881,586 held (−7%) | $196.54 | $1.2M | -21.4% | — |
| Sep 9SEC | Hao-yuan ChuangCFO | Sell Plan | 6,20052,000 held (−11%) | $191.09 | $1.2M | -19.2% | — |
| Sep 9SEC | Hao-yuan ChuangCFO | Sell Plan | 6,20060,000 held (−9%) | $189.22 | $1.2M | -18.4% | — |
| Sep 9SEC | Yu-hsin LinCEO | Sell Plan | 6,200132,134 held (−4%) | $187.25 | $1.2M | -17.5% | — |
| Sep 9SEC | Yu-hsin LinCEO | Sell Plan | 6,252150,727 held (−4%) | $184.52 | $1.2M | -16.3% | — |
| Sep 9SEC | Yu-hsin LinCEO | Sell Plan | 4,955156,979 held (−3%) | $183.30 | $908K | -15.7% | — |
| Sep 9SEC | Hao-yuan ChuangCFO | Sell Plan | 4,60528,600 held (−14%) | $197.23 | $908K | -21.7% | — |
| Sep 9SEC | Hao-yuan ChuangCFO | Sell Plan | 4,60244,000 held (−9%) | $193.12 | $889K | -20.0% | — |
| Sep 9SEC | Hao-yuan ChuangCFO | Sell Plan | 4,47533,205 held (−12%) | $196.47 | $879K | -21.4% | — |
| Sep 9SEC | Hao-yuan ChuangCFO | Sell Plan | 4,60072,000 held (−6%) | $186.35 | $857K | -17.1% | — |
| Sep 9SEC | Yu-hsin LinCEO | Sell Plan | 4,593146,134 held (−3%) | $185.34 | $851K | -16.6% | — |
| Sep 9SEC | Yu-hsin LinCEO | Sell Plan | 4,209104,245 held (−4%) | $192.54 | $810K | -19.8% | — |
| Sep 9SEC | Hao-yuan ChuangCFO | Sell Plan | 4,12037,680 held (−10%) | $195.60 | $806K | -21.0% | — |
| Sep 9SEC | Hao-yuan ChuangCFO | Sell Plan | 3,90068,100 held (−5%) | $187.16 | $730K | -17.5% | — |
| Sep 9SEC | Hao-yuan ChuangCFO | Sell Plan | 3,87276,600 held (−5%) | $185.28 | $717K | -16.6% | — |
| Sep 9SEC | Hao-yuan ChuangCFO | Sell Plan | 3,75984,041 held (−4%) | $183.27 | $689K | -15.7% | — |
| Sep 9SEC | Hao-yuan ChuangCFO | Sell Plan | 3,56980,472 held (−4%) | $184.57 | $659K | -16.3% | — |
| Sep 9SEC | Hao-yuan ChuangCFO | Sell Plan | 3,39848,602 held (−7%) | $192.40 | $654K | -19.7% | — |
| Sep 9SEC | Yu-hsin LinCEO | Sell Plan | 3,413161,934 held (−2%) | $182.50 | $623K | -15.3% | — |
| Sep 9SEC | Yu-hsin LinCEO | Sell Plan | 3,045129,089 held (−2%) | $188.26 | $573K | -17.9% | — |
| Sep 9SEC | Yu-hsin LinCEO | Sell Plan | 2,70070,134 held (−4%) | $198.09 | $535K | -22.0% | — |
| Sep 9SEC | Hao-yuan ChuangCFO | Sell Plan | 2,56226,038 held (−9%) | $198.05 | $507K | -22.0% | — |
| Sep 9SEC | Yu-hsin LinCEO | Sell Plan | 2,635167,934 held (−2%) | $180.29 | $475K | -14.3% | — |
| Sep 9SEC | Yu-hsin LinCEO | Sell Plan | 2,587165,347 held (−2%) | $181.24 | $469K | -14.8% | — |
| Sep 9SEC | Yu-hsin LinCEO | Sell Plan | 2,40093,734 held (−2%) | $194.33 | $466K | -20.5% | — |
| Sep 9SEC | Hao-yuan ChuangCFO | Sell Plan | 2,20041,800 held (−5%) | $194.28 | $427K | -20.5% | — |
| Sep 9SEC | Hao-yuan ChuangCFO | Sell Plan | 2,00087,800 held (−2%) | $182.49 | $365K | -15.3% | — |
| Sep 9SEC | Hao-yuan ChuangCFO | Sell Plan | 2,00089,800 held (−2%) | $181.05 | $362K | -14.7% | — |
| Sep 9SEC | Hao-yuan ChuangCFO | Sell Plan | 1,90066,200 held (−3%) | $188.59 | $358K | -18.1% | — |
| Sep 9SEC | Hao-yuan ChuangCFO | Sell Plan | 1,80058,200 held (−3%) | $190.63 | $343K | -19.0% | — |
| Sep 9SEC | Hao-yuan ChuangCFO | Sell Plan | 1,63391,800 held (−2%) | $180.16 | $294K | -14.2% | — |
| Sep 9SEC | Yu-hsin LinCEO | Sell Plan | 600119,534 held (−0%) | $190.39 | $114K | -18.9% | — |
| Aug 14SEC | Yu-hsin LinCEO | Sell Plan | 223170,569 held (−0%) | $180.57 | $40K | -14.4% | — |
| Aug 14SEC | Hao-yuan ChuangCFO | Sell Plan | 22393,433 held (−0%) | $180.57 | $40K | -14.4% | — |
| Aug 14SEC | Hao-yuan ChuangCFO | Sell Plan | 14493,656 held (−0%) | $180.00 | $26K | -14.2% | — |
| Aug 14SEC | Yu-hsin LinCEO | Sell Plan | 142170,792 held (−0%) | $180.00 | $26K | -14.2% | — |
| Jun 22SEC | Hendrik Peter SchollChief Medical Officer | Sell | 4,86116,295 held (−23%) | $145.43 | $707K | +6.2% | — |
| Jun 22SEC | Hendrik Peter SchollChief Medical Officer | Sell | 3,74821,156 held (−15%) | $144.66 | $542K | +6.8% | — |
| Jun 22SEC | Hendrik Peter SchollChief Medical Officer | Sell | 1,19915,096 held (−7%) | $146.24 | $175K | +5.6% | — |
| Jun 22SEC | Hendrik Peter SchollChief Medical Officer | Sell | 9615,000 held (−1%) | $147.11 | $14K | +5.0% | — |
| Jun 22SEC | Hendrik Peter SchollChief Medical Officer | Sell | 9624,904 held (−0%) | $143.90 | $14K | +7.4% | — |
| Jun 17SEC | Hendrik Peter SchollChief Medical Officer | Sell | 3,14029,022 held (−10%) | $139.57 | $438K | +10.7% | — |
| Jun 17SEC | Hendrik Peter SchollChief Medical Officer | Sell | 2,05432,946 held (−6%) | $137.61 | $283K | +12.3% | — |
| Jun 17SEC | Hendrik Peter SchollChief Medical Officer | Sell | 1,89726,035 held (−7%) | $143.55 | $272K | +7.6% | — |
| Jun 17SEC | Hendrik Peter SchollChief Medical Officer | Sell | 1,03525,000 held (−4%) | $145.02 | $150K | +6.5% | — |
| Jun 17SEC | Hendrik Peter SchollChief Medical Officer | Sell | 78432,162 held (−2%) | $138.18 | $108K | +11.8% | — |
| Jun 17SEC | Hendrik Peter SchollChief Medical Officer | Sell | 54028,482 held (−2%) | $140.58 | $76K | +9.9% | — |
| Jun 17SEC | Hendrik Peter SchollChief Medical Officer | Sell | 45027,932 held (−2%) | $142.20 | $64K | +8.6% | — |
| Jun 17SEC | Hendrik Peter SchollChief Medical Officer | Sell | 10028,382 held (−0%) | $141.83 | $14K | +8.9% | — |
| May 8SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 42812 held (−97%) | $153.56 | $66K | +0.6% | — |
| May 8SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 226440 held (−34%) | $152.45 | $34K | +1.3% | — |
| May 8SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 9 | $155.25 | $1K | -0.5% | — |
| May 8SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 39 held (−25%) | $154.61 | $464 | -0.1% | — |
| May 7SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 4241,234 held (−26%) | $152.67 | $65K | +1.2% | — |
| May 7SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 240866 held (−22%) | $154.41 | $37K | +0.1% | — |
| May 7SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 1281,106 held (−10%) | $153.42 | $20K | +0.7% | — |
| May 7SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 100666 held (−13%) | $156.00 | $16K | -1.0% | — |
| May 7SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 100766 held (−12%) | $155.97 | $16K | -0.9% | — |
| May 7SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 81,658 held (−0%) | $151.57 | $1K | +1.9% | — |
| May 6SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 3632,183 held (−14%) | $154.44 | $56K | +0.0% | — |
| May 6SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 1732,010 held (−8%) | $155.48 | $27K | -0.6% | — |
| May 6SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 1551,734 held (−8%) | $157.29 | $24K | -1.8% | — |
| May 6SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 1211,889 held (−6%) | $156.53 | $19K | -1.3% | — |
| May 6SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 1202,546 held (−5%) | $153.92 | $18K | +0.4% | — |
| May 6SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 681,666 held (−4%) | $158.11 | $11K | -2.3% | — |
| May 5SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 3253,073 held (−10%) | $155.21 | $50K | -0.5% | — |
| May 5SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 2352,838 held (−8%) | $156.57 | $37K | -1.3% | — |
| May 5SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 2363,398 held (−6%) | $154.24 | $36K | +0.2% | — |
| May 5SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 1722,666 held (−6%) | $157.49 | $27K | -1.9% | — |
| May 5SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 323,634 held (−1%) | $153.50 | $5K | +0.6% | — |
| May 4SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 3463,980 held (−8%) | $155.48 | $54K | -0.6% | — |
| May 4SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 2884,326 held (−6%) | $154.38 | $44K | +0.1% | — |
| May 4SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 1063,792 held (−3%) | $157.45 | $17K | -1.9% | — |
| May 4SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 823,898 held (−2%) | $156.24 | $13K | -1.1% | — |
| May 4SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 653,727 held (−2%) | $158.35 | $10K | -2.4% | — |
| May 4SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 524,614 held (−1%) | $153.89 | $8K | +0.4% | — |
| May 4SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 383,689 held (−1%) | $159.08 | $6K | -2.9% | — |
| May 4SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 233,666 held (−1%) | $160.00 | $4K | -3.4% | — |
| May 1SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 5175,107 held (−9%) | $156.59 | $81K | -1.3% | — |
| May 1SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 3404,767 held (−7%) | $157.37 | $54K | -1.8% | — |
| May 1SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 1014,666 held (−2%) | $158.15 | $16K | -2.3% | — |
| May 1SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 425,624 held (−1%) | $155.68 | $7K | -0.8% | — |
| Apr 30SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 3395,790 held (−6%) | $156.43 | $53K | -1.2% | — |
| Apr 30SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 2786,388 held (−4%) | $154.58 | $43K | -0.1% | — |
| Apr 30SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 2596,129 held (−4%) | $155.52 | $40K | -0.7% | — |
| Apr 30SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 1025,688 held (−2%) | $157.39 | $16K | -1.8% | — |
| Apr 30SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 225,666 held (−0%) | $158.19 | $3K | -2.3% | — |
| Apr 29SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 3806,929 held (−5%) | $159.42 | $61K | -3.1% | — |
| Apr 29SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 2227,371 held (−3%) | $157.49 | $35K | -1.9% | — |
| Apr 29SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 1206,809 held (−2%) | $160.27 | $19K | -3.6% | — |
| Apr 29SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 896,720 held (−1%) | $161.72 | $14K | -4.5% | — |
| Apr 29SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 627,309 held (−1%) | $158.71 | $10K | -2.7% | — |
| Apr 29SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 546,666 held (−1%) | $162.14 | $9K | -4.7% | — |
| Apr 29SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 537,593 held (−1%) | $156.61 | $8K | -1.4% | — |
| Apr 29SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 127,654 held (−0%) | $154.65 | $2K | -0.1% | — |
| Apr 29SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 87,646 held (−0%) | $155.36 | $1K | -0.6% | — |
| Apr 28SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 4097,702 held (−5%) | $163.56 | $67K | -5.5% | — |
| Apr 28SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 2808,342 held (−3%) | $161.62 | $45K | -4.4% | — |
| Apr 28SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 2318,111 held (−3%) | $162.38 | $38K | -4.9% | — |
| Apr 28SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 448,622 held (−1%) | $160.83 | $7K | -3.9% | — |
| Apr 28SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 367,666 held (−0%) | $164.07 | $6K | -5.8% | — |
| Apr 27SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 3759,027 held (−4%) | $159.46 | $60K | -3.1% | — |
| Apr 27SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 3308,697 held (−4%) | $160.40 | $53K | -3.7% | — |
| Apr 27SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 1909,402 held (−2%) | $158.65 | $30K | -2.6% | — |
| Apr 27SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 749,592 held (−1%) | $157.86 | $12K | -2.1% | — |
| Apr 27SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 288,669 held (−0%) | $161.22 | $5K | -4.2% | — |
| Apr 27SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 38,666 held (−0%) | $162.53 | $488 | -4.9% | — |
| Apr 24SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 3739,741 held (−4%) | $167.37 | $62K | -7.7% | — |
| Apr 24SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 26710,399 held (−3%) | $164.47 | $44K | -6.1% | — |
| Apr 24SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 15810,241 held (−2%) | $165.38 | $26K | -6.6% | — |
| Apr 24SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 12710,114 held (−1%) | $166.56 | $21K | -7.2% | — |
| Apr 24SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 549,687 held (−1%) | $168.43 | $9K | -8.3% | — |
| Apr 24SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 219,666 held (−0%) | $169.56 | $4K | -8.9% | — |
| Apr 23SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 25710,936 held (−2%) | $171.62 | $44K | -10.0% | — |
| Apr 23SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 24910,687 held (−2%) | $172.49 | $43K | -10.4% | — |
| Apr 23SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 14111,474 held (−1%) | $167.42 | $24K | -7.7% | — |
| Apr 23SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 10511,268 held (−1%) | $169.52 | $18K | -8.9% | — |
| Apr 23SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 10111,373 held (−1%) | $168.64 | $17K | -8.4% | — |
| Apr 23SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 7511,193 held (−1%) | $170.58 | $13K | -9.4% | — |
| Apr 23SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 3111,635 held (−0%) | $165.70 | $5K | -6.8% | — |
| Apr 23SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 2110,666 held (−0%) | $173.04 | $4K | -10.7% | — |
| Apr 23SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 2011,615 held (−0%) | $166.32 | $3K | -7.1% | — |
| Apr 22SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 33212,192 held (−3%) | $165.49 | $55K | -6.6% | — |
| Apr 22SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 31211,880 held (−3%) | $166.49 | $52K | -7.2% | — |
| Apr 22SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 21411,666 held (−2%) | $167.34 | $36K | -7.7% | — |
| Apr 22SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 7812,524 held (−1%) | $164.60 | $13K | -6.1% | — |
| Apr 22SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 6412,602 held (−1%) | $163.49 | $10K | -5.5% | — |
| Apr 21SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 52412,858 held (−4%) | $163.52 | $86K | -5.5% | — |
| Apr 21SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 28413,382 held (−2%) | $162.76 | $46K | -5.1% | — |
| Apr 21SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 12412,734 held (−1%) | $164.40 | $20K | -6.0% | — |
| Apr 21SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 4012,694 held (−0%) | $165.29 | $7K | -6.5% | — |
| Apr 21SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 1612,675 held (−0%) | $167.17 | $3K | -7.6% | — |
| Apr 21SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 912,666 held (−0%) | $168.35 | $2K | -8.2% | — |
| Apr 21SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 312,691 held (−0%) | $166.91 | $501 | -7.4% | — |
| Apr 20SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 27414,082 held (−2%) | $161.41 | $44K | -4.3% | — |
| Apr 20SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 24014,790 held (−2%) | $161.61 | $39K | -4.4% | — |
| Apr 20SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 22614,356 held (−2%) | $160.55 | $36K | -3.8% | — |
| Apr 20SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 21613,866 held (−2%) | $162.48 | $35K | -4.9% | — |
| Apr 20SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 21915,231 held (−1%) | $159.81 | $35K | -3.3% | — |
| Apr 20SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 21615,450 held (−1%) | $158.28 | $34K | -2.4% | — |
| Apr 20SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 20013,666 held (−1%) | $163.33 | $33K | -5.4% | — |
| Apr 20SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 20115,030 held (−1%) | $160.35 | $32K | -3.7% | — |
| Apr 20SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 7614,714 held (−1%) | $162.26 | $12K | -4.8% | — |
| Apr 20SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 5214,582 held (−0%) | $159.38 | $8K | -3.1% | — |
| Apr 20SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 3614,678 held (−0%) | $163.21 | $6K | -5.3% | — |
| Apr 20SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 3214,634 held (−0%) | $158.46 | $5K | -2.5% | — |
| Apr 20SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 1214,666 held (−0%) | $164.12 | $2K | -5.9% | — |
| Apr 16SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 53715,746 held (−3%) | $168.64 | $91K | -8.4% | — |
| Apr 16SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 38316,283 held (−2%) | $167.58 | $64K | -7.8% | — |
| Apr 16SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 6815,678 held (−0%) | $169.15 | $12K | -8.7% | — |
| Apr 16SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 815,670 held (−0%) | $170.77 | $1K | -9.5% | — |
| Apr 16SEC | Nathan L. MataChief Scientific Officer | Sell Plan | 415,666 held (−0%) | $171.19 | $685 | -9.8% | — |
| Apr 13SEC | Yu-hsin LinCEO | Sell Plan | 3,500174,134 held (−2%) | $181.33 | $635K | -14.8% | — |
| Apr 13SEC | Yu-hsin LinCEO | Sell Plan | 3,000171,134 held (−2%) | $182.40 | $547K | -15.3% | — |
| Apr 13SEC | Yu-hsin LinCEO | Sell Plan | 2,500177,634 held (−1%) | $180.36 | $451K | -14.3% | — |
| Apr 13SEC | Hao-yuan ChuangCFO | Sell Plan | 2,00096,000 held (−2%) | $181.40 | $363K | -14.8% | — |
| Apr 13SEC | Hao-yuan ChuangCFO | Sell Plan | 2,00098,000 held (−2%) | $180.35 | $361K | -14.3% | — |
| Apr 13SEC | Hao-yuan ChuangCFO | Sell Plan | 1,90994,091 held (−2%) | $182.58 | $349K | -15.4% | — |
| Apr 13SEC | Wan-shan ChenDirector | Sell Plan | 1,1009,096 held (−11%) | $180.43 | $198K | -14.4% | — |
| Apr 13SEC | Hao-yuan ChuangCFO | Sell Plan | 29193,800 held (−0%) | $183.08 | $53K | -15.6% | — |
| Apr 13SEC | Yu-hsin LinCEO | Sell Plan | 200170,934 held (−0%) | $183.00 | $37K | -15.6% | — |
Insiders at BELITE BIO, INC
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Yu-hsin LinCEO | — | $20.8M | Sep 9, 2026 | — |
| Hao-yuan ChuangCFO | — | $14.0M | Sep 9, 2026 | — |
| Hendrik Peter SchollChief Medical Officer | — | $2.9M | Oct 5, 2026 | — |
| Nathan L. MataChief Scientific Officer | — | $2.7M | May 8, 2026 | — |
| Wan-shan ChenDirector | — | $198K | Apr 13, 2026 | — |
BLTE stock: common questions
Are BELITE BIO, INC insiders buying BLTE stock?
In the past 12 months, 0 insiders reported open-market purchases of BLTE worth $0.
Are BELITE BIO, INC insiders selling BLTE stock?
5 insiders reported sales worth $40.6M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is BLTE's 52-week range?
Over the past year BLTE has traded between $78.50 and $193.61. It last closed at $154.49 on Oct 9, 2026.